Ticlid 250

Generic Name: ticlopidine

Pill imprint Ticlid 250 has been identified as Ticlid 250 mg.

Ticlid is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.

Ticlid 250 mg is not subject to the Controlled Substances Act.
See also related documents.

Ticlid Images

Generic Name:
ticlopidine
Imprint:
Ticlid
250
Strength:
250 mg
Color:
White
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Inactive Ingredients:
citric acid
magnesium stearate
microcrystalline cellulose
povidone
starch
stearic acid
polyethylene glycol
titanium dioxide
FD&C Blue No. 1 Aluminium Lake
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-0018
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-3783 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Ticlid 250 mg Ticlid 250
Ticlid 250 mg Ticlid 250
Advertisement

Ticlid is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web1)